References
- ADA. (2020). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2020. Diabetes Care, 43(Suppl.1), S14–S31. https://doi.org/10.2337/dc20-S002
- Alshehri, M. M. (2018). The Effect of cognitive behavioral therapy for insomnia on type 2 diabetes health outcomes: ClinicalTrirals.gov https://clinicaltrials.gov/ct2/show/record/NCT03713996?cond=The+Effect+of+Cognitive+Behavioral+Therapy+for+Insomnia+on+Type+2+Diabetes+Health+Outcomes&rank=1
- Alshehri, M. M., Alenazi, A. M., Hoover, J. C., Alothman, S. A., Phadnis, M. A., Miles, J. M., Kluding, P. M., & Siengsukon, C. F. (2020). A comparison of diabetes self-care behavior in people with type 2 diabetes with and without insomnia symptoms. Acta Diabetologica, 1–9.
- Alshehri, M. M., Alenazi, A. M., Hoover, J. C., Alothman, S. A., Phadnis, M. A., Rucker, J. L., Befort, C. A., Miles, J. M., Kluding, P. M., & Siengsukon, C. F. (2019). Effect of cognitive behavioral therapy for insomnia on insomnia symptoms for individuals with type 2 diabetes: Protocol for a pilot randomized controlled trial. JMIR Research Protocols, 8(12), e14647. https://doi.org/10.2196/14647
- Ancoli-Israel, S., Bliwise, D. L., & Nørgaard, J. P. (2011). The effect of nocturia on sleep. Sleep Medicine Reviews, 15(2), 91–97. https://doi.org/10.1016/j.smrv.2010.03.002
- Ancoli-Israel, S., Martin, J. L., Blackwell, T., Buenaver, L., Liu, L., Meltzer, L. J., Sadeh, A., Spira, A. P., & Taylor, D. J. (2015). The SBSM guide to actigraphy monitoring: Clinical and research applications. Behavioral Sleep Medicine, 13(Suppl 1), S4–s38. https://doi.org/10.1080/15402002.2015.1046356
- Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297–307. https://doi.org/10.1016/S1389-9457(00)00065-4
- Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory-II. San Antonio, 78(2), 490–498.
- Beck, A. T., Steer, R. A., & Carbin, M. G. (1988). Psychometric properties of the beck depression inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8(1), 77–100. https://doi.org/10.1016/0272-7358(88)90050-5
- Bei, B., Wiley, J. F., Trinder, J., & Manber, R. (2016). Beyond the mean: A systematic review on the correlates of daily intraindividual variability of sleep/wake patterns. Sleep Medicine Reviews, 28, 108–124. https://doi.org/org/10.1016/j.smrv.2015.06.003
- Buckley, T. M., & Schatzberg, A. F. (2005). On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: Normal HPA axis activity and circadian rhythm, exemplary sleep disorders. The Journal of Clinical Endocrinology & Metabolism, 90(5), 3106–3114. https://doi.org/10.1210/jc.2004-1056
- Button, K. S., Kounali, D., Thomas, L., Wiles, N. J., Peters, T. J., Welton, N. J., Ades, A. E., & Lewis, G. (2015). Minimal clinically important difference on the beck depression inventory–II according to the patient’s perspective. Psychological Medicine, 45(15), 3269–3279. https://doi.org/10.1017/S0033291715001270
- Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res, 28(2), 193–213. https://doi.org/10.1016/0165-1781(89)90047-4
- CDC. (2017). National diabetes statistics report, 2017. Centers for Disease Control and Prevention, US Department of Health and Human Services, 20.
- Chaput, J.-P., Després, J.-P., Bouchard, C., & Tremblay, A. (2007). Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia, 50(11), 2298–2304. https://doi.org/10.1007/s00125-007-0786-x
- Chasens, E. R., Korytkowski, M., Sereika, S. M., & Burke, L. E. (2013). Effect of poor sleep quality and excessive daytime sleepiness on factors associated with diabetes self-management. The Diabetes Educator, 39(1), 74–82. https://doi.org/10.1177/0145721712467683
- Cohen, J. (2013). Statistical power analysis for the behavioral sciences. Academic press.
- Cole, R. J., Kripke, D. F., Gruen, W., Mullaney, D. J., & Gillin, J. C. (1992). Automatic sleep/wake identification from wrist activity. Sleep, 15(5), 461–469. https://doi.org/10.1093/sleep/15.5.461
- Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018). Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care, 41(12), 2669–2701. https://doi.org/10.2337/dci18-0033
- Edinger, J. D., Olsen, M. K., Stechuchak, K. M., Means, M. K., Lineberger, M. D., Kirby, A., & Carney, C. E. (2009). Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: A randomized clinical trial. Sleep, 32(4), 499–510. https://doi.org/10.1093/sleep/32.4.499
- Fernandez-Mendoza, J., Calhoun, S. L., Bixler, E. O., Karataraki, M., Liao, D., Vela-Bueno, A., Ramos-Platon, M. J., Sauder, K. A., Basta, M., & Vgontzas, A. N. (2011). Sleep misperception and chronic insomnia in the general population: The role of objective sleep duration and psychological profiles. Psychosomatic Medicine, 73(1), 88. https://doi.org/10.1097/PSY.0b013e3181fe365a
- Geiger-Brown, J. M., Rogers, V. E., Liu, W., Ludeman, E. M., Downton, K. D., & Diaz-Abad, M. (2015). Cognitive behavioral therapy in persons with comorbid insomnia: A meta-analysis. Sleep Medicine Reviews, 23, 54–67. https://doi.org/org/10.1016/j.smrv.2014.11.007
- Gramaglia, E., Ramella Gigliardi, V., Olivetti, I., Tomelini, M., Belcastro, S., Calvi, E., Dotta, A., Ghigo, E., Benso, A., & Broglio, F. (2014). Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects. Journal of Endocrinological Investigation, 37(2), 203–206. https://doi.org/10.1007/s40618-013-0016-y
- Heller, S. R. (2002). Hypoglycaemia in diabetes. Medicine, 30(2), 54–57. https://doi.org/10.1383/medc.30.2.54.28268
- Heron, M. P. (2016). Deaths: leading causes for 2013.
- Holingue, C., Wennberg, A., Berger, S., Polotsky, V. Y., & Spira, A. P. (2018). Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism, 84, 85–93. https://doi.org/10.1016/j.metabol.2018.01.021
- Johnson, E. O., Roth, T., & Breslau, N. (2006). The association of insomnia with anxiety disorders and depression: Exploration of the direction of risk. Journal of Psychiatric Research, 40(8), 700–708. https://doi.org/10.1016/j.jpsychires.2006.07.008
- Jungquist, C. R., O’Brien, C., Matteson-Rusby, S., Smith, M. T., Pigeon, W. R., Xia, Y., Lu, N., & Perlis, M. L. (2010). The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic pain. Sleep Medicine, 11(3), 302–309. https://doi.org/10.1016/j.sleep.2009.05.018
- Kim, J., & Shin, W. (2014). How to do random allocation (randomization). Clinics in Orthopedic Surgery, 6(1), 103–109. https://doi.org/10.4055/cios.2014.6.1.103
- Knutson, K. L., Ryden, A. M., Mander, B. A., & Van Cauter, E. (2006). Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Archives of Internal Medicine, 166(16), 1768–1774. https://doi.org/10.1001/archinte.166.16.1768
- Koffel, E. A., Koffel, J. B., & Gehrman, P. R. (2015). A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Medicine Reviews, 19, 6–16. https://doi.org/10.1016/j.smrv.2014.05.001
- Koopman, A. D. M., Beulens, J. W., Dijkstra, T., Pouwer, F., Bremmer, M. A., van Straten, A., & Rutters, F. (2019). Prevalence of insomnia (symptoms) in T2D and association with metabolic parameters and glycemic control: Meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 105(3), 614–643. https://doi.org/10.1210/clinem/dgz065
- Kripke, D. F. (2016). Mortality risk of hypnotics: Strengths and limits of evidence. Drug Safety, 39(2), 93–107. https://doi.org/10.1007/s40264-015-0362-0
- Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2010). The patient health questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. General Hospital Psychiatry, 32(4), 345–359. https://doi.org/10.1016/j.genhosppsych.2010.03.006
- Kroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016). Patient health questionnaire anxiety and depression scale: Initial validation in three clinical trials. Psychosomatic Medicine, 78(6), 716–727. https://doi.org/10.1097/PSY.0000000000000322
- Lacks, P. (1987). Behavioral treatment for persistent insomnia. Pergamon Press.
- Lamond, N., Tiggemann, M., & Dawson, D. (2000). Factors predicting sleep disruption in type II diabetes. Sleep, 23(3), 415–416. https://doi.org/10.1093/sleep/23.3.1i
- Lecube, A., Sánchez, E., Gómez-Peralta, F., Abreu, C., Valls, J., Mestre, O., Romero, O., Martínez, M. D., Sampol, G., Ciudin, A., Hernández, C., & Simó, R. (2016). Global assessment of the impact of type 2 diabetes on sleep through specific questionnaires. A case-control study. PloS One, 11(6), e0157579–e0157579. https://doi.org/10.1371/journal.pone.0157579
- Lichstein, K. L., Stone, K. C., Donaldson, J., Nau, S. D., Soeffing, J. P., Murray, D., Lester, K. W., & Aguillard, R. N. (2006). Actigraphy validation with insomnia. Sleep, 29(2), 232–239.
- Lin, C. L., Yeh, M. C., Harnod, T., Lin, C. L., & Kao, C. H. (2015). Risk of type 2 diabetes in patients with nonapnea sleep disorders in using different types of hypnotics: A population-based retrospective cohort study. Medicine (Baltimore), 94(38), e1621. https://doi.org/10.1097/md.0000000000001621
- Liu, Y. (2016). Prevalence of healthy sleep duration among adults—United States, 2014. MMWR. Morbidity and Mortality Weekly Report, 65(6), 137–141. https://doi.org/10.15585/mmwr.mm6506a1
- Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008). Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care, 46(3), 266–274. https://doi.org/10.1097/MLR.0b013e318160d093
- Luyster, F. S., & Dunbar-Jacob, J. (2011). Sleep quality and quality of life in adults with type 2 diabetes. The Diabetes Educator, 37(3), 347–355. https://doi.org/10.1177/0145721711400663
- Manber, R., Edinger, J. D., Gress, J. L., Pedro-Salcedo, M. G. S., Kuo, T. F., & Kalista, T. (2008). Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep, 31(4), 489–495. https://doi.org/10.1093/sleep/31.4.489
- Mokhlesi, B., Temple, K. A., Tjaden, A. H., Edelstein, S. L., Utzschneider, K. M., Nadeau, K. J., Hannon, T. S., Sam, S., Barengolts, E., & Manchanda, S. (2019). Association of self-reported sleep and circadian measures with glycemia in adults with prediabetes or recently diagnosed untreated type 2 diabetes. Diabetes Care, 42(7), 1326–1332. https://doi.org/10.2337/dc19-0298
- Morgenthaler, T., Kramer, M., Alessi, C., Friedman, L., Boehlecke, B., Brown, T., Coleman, J., Kapur, V., Lee-Chiong, T., Owens, J., Pancer, J., & Swick, T.; American Academy of Sleep, M. (2006). Practice parameters for the psychological and behavioral treatment of insomnia: An update. An american academy of sleep medicine report. Sleep, 29(11), 1415–1419. https://www.ncbi.nlm.nih.gov/pubmed/17162987
- Morin, C. M., Belleville, G., Bélanger, L., & Ivers, H. (2011). The insomnia severity index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep, 34(5), 601–608. https://doi.org/10.1093/sleep/34.5.601
- Nakanishi-Minami, T., Kishida, K., Funahashi, T., & Shimomura, I. (2012). Sleep-wake cycle irregularities in type 2 diabetics. Diabetology & Metabolic Syndrome, 4(1), 18. https://doi.org/10.1186/1758-5996-4-18
- Natale, V., Léger, D., Bayon, V., Erbacci, A., Tonetti, L., Fabbri, M., & Martoni, M. (2015). The consensus sleep diary: Quantitative criteria for primary insomnia diagnosis. Psychosomatic Medicine, 77(4), 413–418. https://doi.org/10.1097/psy.0000000000000177
- Natale, V., Léger, D., Martoni, M., Bayon, V., & Erbacci, A. (2014). The role of actigraphy in the assessment of primary insomnia: A retrospective study. Sleep Medicine, 15(1), 111–115. https://doi.org/org/10.1016/j.sleep.2013.08.792
- Ong, J. C., Kuo, T. F., & Manber, R. (2008). Who is at risk for dropout from group cognitive-behavior therapy for insomnia? Journal of Psychosomatic Research, 64(4), 419–425. https://doi.org/10.1016/j.jpsychores.2007.10.009
- Otte, J. L., Payne, J. K., & Carpenter, J. S. (2011). Nighttime variability in wrist actigraphy. Journal of Nursing Measurement, 19(2), 105–114. https://doi.org/10.1891/1061-3749.19.2.105
- Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D. (2006). Cognitive behavioral treatment of insomnia: A session-by-session guide (Vol. 1). Springer Science & Business Media.
- Peyrot, M., McMurry, J. J. F., & Kruger, D. F. (1999). A biopsychosocial model of glycemic control in diabetes: Stress, coping and regimen adherence. Journal of Health and Social Behavior, 40(2), 141–158. https://doi.org/10.2307/2676370
- Roth, T. (2007). Insomnia: Definition, prevalence, etiology, and consequences. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine, 3(5Suppl), S7–S10. https://www.ncbi.nlm.nih.gov/pubmed/17824495 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978319/
- Scheer, F. A., Hilton, M. F., Mantzoros, C. S., & Shea, S. A. (2009). Adverse metabolic and cardiovascular consequences of circadian misalignment. Proceedings of the National Academy of Sciences, 106(11), 4453–4458. https://doi.org/10.1073/pnas.0808180106
- Schmid, S. M., Hallschmid, M., Jauch-Chara, K., Bandorf, N., Born, J., & Schultes, B. (2007). Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia. The Journal of Clinical Endocrinology & Metabolism, 92(8), 3044–3051. https://doi.org/10.1210/jc.2006-2788
- Seow, L. S. E., Abdin, E., Chang, S., Chong, S. A., & Subramaniam, M. (2018). Identifying the best sleep measure to screen clinical insomnia in a psychiatric population. Sleep Medicine, 41, 86–93. https://doi.org/10.1016/j.sleep.2017.09.015
- Shan, Z., Ma, H., Xie, M., Yan, P., Guo, Y., Bao, W., Rong, Y., Jackson, C. L., Hu, F. B., & Liu, L. (2015). Sleep duration and risk of type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care, 38(3), 529–537. https://doi.org/10.2337/dc14-2073
- Skomro, R. P., Ludwig, S., Salamon, E., & Kryger, M. H. (2001). Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Medicine, 2(5), 417–422. https://doi.org/org/10.1016/S1389-9457(01)00110-1
- Smith, M. T., Huang, M. I., & Manber, R. (2005). Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clinical Psychology Review, 25(5), 559–592. https://doi.org/org/10.1016/j.cpr.2005.04.004
- Spiegel, K., Knutson, K., Leproult, R., Tasali, E., & Cauter, E. V. (2005). Sleep loss: A novel risk factor for insulin resistance and type 2 diabetes. Journal of Applied Physiology, 99(5), 2008–2019. https://doi.org/10.1152/japplphysiol.00660.2005
- Suh, S., Nowakowski, S., Bernert, R. A., Ong, J. C., Siebern, A. T., Dowdle, C. L., & Manber, R. (2012). Clinical significance of night-to-night sleep variability in insomnia. Sleep Medicine, 13(5), 469–475. https://doi.org/10.1016/j.sleep.2011.10.034
- Taylor, D. J., Mallory, L. J., Lichstein, K. L., Durrence, H. H., Riedel, B. W., & Bush, A. J. (2007). Comorbidity of chronic insomnia with medical problems. Sleep, 30(2), 213–218. https://doi.org/10.1093/sleep/30.2.213
- Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M., & Cunnington, D. (2015). Cognitive behavioral therapy for chronic insomnia: A systematic review and meta-analysis. Annals of Internal Medicine, 163(3), 191–204. https://doi.org/10.7326/M14-2841
- Trento, M., Broglio, F., Riganti, F., Basile, M., Borgo, E., Kucich, C., Passera, P., Tibaldi, P., Tomelini, M., & Cavallo, F. (2008). Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetologica, 45(4), 225–229. https://doi.org/10.1007/s00592-008-0047-6
- Troxel, W. M., Conrad, T. S., Germain, A., & Buysse, D. J. (2013). Predictors of treatment response to brief behavioral treatment of insomnia (BBTI) in older adults. Journal of Clinical Sleep Medicine, 9(12), 1281–1289. https://doi.org/10.5664/jcsm.3270
- Vgontzas, A. N., Liao, D., Pejovic, S., Calhoun, S., Karataraki, M., & Bixler, E. O. (2009). Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care, 32(11), 1980–1985. https://doi.org/10.2337/dc09-0284
- Zelman, D. C., Gore, M., Dukes, E., Tai, K.-S., & Brandenburg, N. (2005). Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy. Journal of Vascular Nursing, 23(3), 97–104. https://doi.org/10.1016/j.jvn.2005.06.004
- Zhu, B., Bronas, U. G., & Fritschi, C. (2018). Sleep assessment in aging adults with type 2 diabetes: Agreement between actigraphy and sleep diaries. Sleep Medicine, 46, 88–94. https://doi.org/org/10.1016/j.sleep.2018.03.008
- Zhu, B., Hershberger, P. E., Kapella, M. C., & Fritschi, C. (2017). The relationship between sleep disturbance and glycaemic control in adults with type 2 diabetes: An integrative review. Journal of Clinical Nursing, 26(23–24), 4053–4064. https://doi.org/10.1111/jocn.13899